Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1007762

registered interest
date	15/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dementia
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he has targets for improvements to care and services for people with dementia over the period of this Parliament.
tabling member constituency	East Londonderry
tabling member printed	Mr Gregory Campbell
uin	191881
answer	answer is ministerial correction date of answer 20/11/2018 answer text <p>Dementia remains a key priority for the Government. We will implement the Prime Minister’s Challenge on Dementia 2020 (published in February 2015) in full to make sure the lives of those with dementia are transformed by 2020.</p><p> </p><p>Working with our partners, we continue to make progress against the ambitions set in the March 2016 Implementation Plan which details how the commitments in the Challenge, across the four core themes of risk reduction, health and care, awareness and social action, and research will be met. This is reflected in the specific expectation set in the mandate to NHS England 2018/19 that two thirds of people living with dementia should receive a formal diagnosis. As of October 2018, the dementia diagnosis rate was 67.9%.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 20/11/2018 15:37:58 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	1409 label Biography information for Mr Gregory Campbell

1007773

registered interest
date	15/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	HIV Infection: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 21 June 2018 to Question 153280 on HIV Infection: drugs, if he will publish the outcome of the interviews with women to explore the facilitators and barriers to accessing the HIV pre-exposure prophylaxis.
tabling member constituency	Rotherham
tabling member printed	Sarah Champion
uin	191930
answer	answer is ministerial correction date of answer 20/11/2018 answer text <p>In line with the guidance governing research, the HIV Pre-Exposure Prophylaxis (PrEP) Impact Trial is currently unable to provide any detailed breakdown of information about participants. This is to preserve the integrity of the emerging data. A planned interim analysis including further demographic breakdown is planned early next year.</p><p> </p><p>An evaluation report will be available after the completion of the trial in 2021 which is expected to include the facilitators and barriers to accessing HIV pre-exposure prophylaxis across all groups, including women.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 191929 191931 191932 question first answered 20/11/2018 15:03:05 answering member 4067 label Biography information for Steve Brine
tabling member	4267 label Biography information for Sarah Champion

1007775

registered interest
date	15/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	HIV Infection: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 21 June 2018 to Question 153280 on HIV Infection: Drugs, how many women have joined the HIV pre-exposure prophylaxis impact trial to date.
tabling member constituency	Rotherham
tabling member printed	Sarah Champion
uin	191931
answer	answer is ministerial correction date of answer 20/11/2018 answer text <p>In line with the guidance governing research, the HIV Pre-Exposure Prophylaxis (PrEP) Impact Trial is currently unable to provide any detailed breakdown of information about participants. This is to preserve the integrity of the emerging data. A planned interim analysis including further demographic breakdown is planned early next year.</p><p> </p><p>An evaluation report will be available after the completion of the trial in 2021 which is expected to include the facilitators and barriers to accessing HIV pre-exposure prophylaxis across all groups, including women.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 191929 191930 191932 question first answered 20/11/2018 15:03:05 answering member 4067 label Biography information for Steve Brine
tabling member	4267 label Biography information for Sarah Champion

1007776

registered interest
date	15/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	HIV Infection: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 21 June 2018 to Question 153280 on HIV Infection: Drugs, how many women who are victims of domestic violence have joined the HIV pre-exposure prophylaxis impact trial to date.
tabling member constituency	Rotherham
tabling member printed	Sarah Champion
uin	191932
answer	answer is ministerial correction date of answer 20/11/2018 answer text <p>In line with the guidance governing research, the HIV Pre-Exposure Prophylaxis (PrEP) Impact Trial is currently unable to provide any detailed breakdown of information about participants. This is to preserve the integrity of the emerging data. A planned interim analysis including further demographic breakdown is planned early next year.</p><p> </p><p>An evaluation report will be available after the completion of the trial in 2021 which is expected to include the facilitators and barriers to accessing HIV pre-exposure prophylaxis across all groups, including women.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 191929 191930 191931 question first answered 20/11/2018 15:03:05 answering member 4067 label Biography information for Steve Brine
tabling member	4267 label Biography information for Sarah Champion

1007820

registered interest
date	15/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cervical Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of women in (a) Oxfordshire and (b) Oxford West and Abingdon constituency who did not receive a cervical screening invitation and reminder letter between January and June 2018.
tabling member constituency	Oxford West and Abingdon
tabling member printed	Layla Moran
uin	191987
answer	answer is ministerial correction date of answer 20/11/2018 answer text <p>We understand from NHS England that no women registered in Oxfordshire and Oxford West and Abingdon constituency were affected by the recent failure to send out cervical screening invitation and reminder letters between January and June 2018.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 20/11/2018 15:04:42 answering member 4067 label Biography information for Steve Brine
tabling member	4656 label Biography information for Layla Moran

1007861

registered interest
date	15/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cervical Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the whether the cervical screening programme IT system is fit for purpose.
tabling member constituency	Heywood and Middleton
tabling member printed	Liz McInnes
uin	191937
answer	answer is ministerial correction date of answer 20/11/2018 answer text <p>Following the recent cervical screening incident, announced on 15 November 2018, NHS England has set up a multi-agency clinical panel to manage the incident. Capita has put in place daily audits to ensure all women’s files are accounted for and are looking at how automated processes can be used to reduce errors. Additionally, the checks within the Capita call and recall service have been upgraded at every stage of the process and Capita has appointed an independent audit team to carry out a detailed review into operation systems and processes in Primary Care Support England.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 20/11/2018 15:05:38 answering member 4067 label Biography information for Steve Brine
tabling member	4342 label Biography information for Liz McInnes

1005988

registered interest
date	13/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Electronic Cigarettes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the implications are for his policies of the evidence from Public Health England and Cancer Research UK that one of the most effective ways to stop smoking is to use vape products.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	190884
answer	answer is ministerial correction date of answer 20/11/2018 answer text <p>The Government is committed to reducing public health harms caused by smoking and has consistently highlighted that quitting smoking and nicotine use is the best way to improve health. E-cigarettes are not risk free. However, the evidence is increasingly clear that vaping is significantly less harmful to health than smoking tobacco and can be particularly useful in supporting smokers to quit, especially when combined with stop smoking services.</p><p> </p><p>The most recent evidence report review from Public Health England, published on 6 February 2018, argues that e-cigarette use, alone or in combination with licensed medication and behavioural support from a stop smoking service appears to be helpful in the short-term, and that e-cigarettes have contributed to tens of thousands of additional quitters in England.</p><p> </p><p>The Department will continue to monitor the impact of regulation and policy on e-cigarettes and novel tobacco products in England, including evidence on safety, uptake, health impact and effectiveness of these products as smoking cessation aids, to inform our future policy.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 20/11/2018 15:10:02 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

1005989

registered interest
date	13/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Electronic Cigarettes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the effectiveness of the regulation of non-nicotine liquid for vape products and nicotine shots.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	190885
answer	answer is ministerial correction date of answer 20/11/2018 answer text <p>Nicotine shots are regulated under the Tobacco and Related Products Regulation 2016 as they are a nicotine containing product. As shortfills do not contain nicotine when sold they are not regulated under the Tobacco and Related Products Regulations 2016 (TRPR), but are covered by General Product Safety Regulations.</p><p> </p><p>The Government is committed to conduct a review of the TRPR at a later date.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 20/11/2018 15:08:46 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

1006014

registered interest
date	13/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Gambling
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if his Department will make an assessment of the effectiveness of the NHS in supporting people who have a gambling addiction.
tabling member constituency	Bexleyheath and Crayford
tabling member printed	Sir David Evennett
uin	190799
answer	answer is ministerial correction date of answer 20/11/2018 answer text <p>Many people with gambling problems will receive treatment from the National Health Service. There are a range of services available to problem gamblers, details of which can be found on the NHS Choices website at the following link:</p><p> </p><p><a href="http://www.nhs.uk/Livewell/addiction/Pages/gamblingaddiction.aspx" target="_blank">www.nhs.uk/Livewell/addiction/Pages/gamblingaddiction.aspx</a></p><p> </p><p>Specialist facilities are provided through industry funding. Central and North West London NHS Foundation Trust has a national problem gambling clinic which accepts referrals from all over the United Kingdom. Further details are available at the following link:</p><p> </p><p><a href="http://www.cnwl.nhs.uk/cnwl-national-problem-gambling-clinic/" target="_blank">http://www.cnwl.nhs.uk/cnwl-national-problem-gambling-clinic/</a></p><p> </p><p>The National Institute for Health and Care Excellence has been commissioned to explore developing a guideline on non-chemical addictions, including gambling, which will give support to clinicians seeking to support problem gamblers.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 20/11/2018 15:11:33 answering member 4067 label Biography information for Steve Brine
tabling member	1198 label Biography information for Sir David Evennett

1006074

registered interest
date	13/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prescription Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 24 October 2018 to Question 180245 on Prescription Drugs, for what reason his Department did not include individual testimony; and what proportion of the published evidence was submitted by pharmaceutical companies.
tabling member constituency	Lancaster and Fleetwood
tabling member printed	Cat Smith
uin	190913
answer	answer is ministerial correction date of answer 20/11/2018 answer text <p>‘Prescribed Medicines: An Evidence Review’ is a public health evidence review of the published evidence and available data. This process is distinct from a public inquiry so the inclusion of individual testimonies would not be appropriate.</p><p> </p><p>Public Health England (PHE) is aware of the importance and relevance of the experience of patients in understanding the issues. The review will give significant prominence to the patients’ experiences and examine existing service models through published research and other methods, for example analysis of annual reports of various withdrawal charities.</p><p> </p><p>The call for evidence was open to all parties, including pharmaceutical companies. The call for evidence has now closed. The National Guideline Centre (NGC) will provide details on the evidence submitted in their rapid evidence assessment report. The report is due in early 2019.</p><p> </p><p>A non-disclosure agreement was not made between PHE and the NGC in relation to the review of literature on prescribed medicines.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 190914 question first answered 20/11/2018 15:07:46 answering member 4067 label Biography information for Steve Brine
tabling member	4436 label Biography information for Cat Smith